Xenotransplantation of the kidney: a pediatric perspective
Abstract The major factor limiting the application of allotransplantation for the treatment of renal failure is a severe shortage of donor organs. One approach to overcoming this limitation is the use of kidneys from animals for clinical transplantation, that is xenotransplantation. Although of i... Ausführliche Beschreibung
|1. Person:||Platt, J. L.|
in Pediatric nephrology : journal of the International Pediatric Nephrology Association Vol. 13 (1999), p. 966-973
|Genre:||Key words Transplantation, Xenotransplantation, Natural antibodies, Complement, Hyperacute rejection, Acute vascular rejection, Endothelium|
Keine Tags. Fügen Sie den ersten Tag hinzu!
Copyright: Copyright 1999 IPNA - International Pediatric Nephrology Association New York, USA
Abstract The major factor limiting the application of allotransplantation for the treatment of renal failure is a severe shortage of donor organs. One approach to overcoming this limitation is the use of kidneys from animals for clinical transplantation, that is xenotransplantation. Although of interest for many years, the application of xenotransplantation has been prevented because of the devastating immune responses of the recipient against the graft. Research conducted in recent years has elucidated the immune mechanisms underlying the rejection of xenografts and has led to the development of incisive therapeutic strategies, including the genetic engineering of donor animals. Success in dealing with the xenogeneic immune response has encouraged the view that xenotransplantation might be feasible in the near future. It also raises consideration of two additional hurdles, the potential limitations of xenogeneic kidneys as physiological replacement for human kidneys and the possibility that the animal organ might transfer infectious organisms to the recipient and to the wider population. This paper reviews recent progress in the field of xenotransplantation of the kidney and offers a perspective on the hurdles to clinical application that remain.